Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.4940
-0.0183-3.57%
Pre-market: 0.50000.0060+1.21%04:55 EDT
Volume:134.49K
Turnover:67.94K
Market Cap:3.13M
PE:-0.03
High:0.5215
Open:0.5160
Low:0.4714
Close:0.5123
52wk High:52.50
52wk Low:0.4714
Shares:6.33M
Float Shares:5.32M
Volume Ratio:0.51
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.6157
EPS(LYR):-371.2241
ROE:-161.86%
ROA:-70.14%
PB:0.33
PE(LYR):0.00

Loading ...

Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Apr 08, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 02, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 31, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 30, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 12, 2024

Major Issues Report

Form 8-K - Current report